Programme

Programme is subject to change

7.45am - 8.30am	Registration open and coffee
8.35am - 8.45am	Welcome / Mihi Ah-Leen Rayner (BCFNZ), Kaumatua Bill Nathan
8.45am - 10.15am	Plenary session: Outcomes that matter Chair: David Okonji
8.50am – 9.00am	The Minister of Health Hon Dr Shane Reti
9.00am – 9.15am	Q+A discussion
9.15am – 9.40am	Outcomes that matter Christobel Saunders \| AUS
9:40am – 10:00am	Lancet Commission on Breast Cancer: Tackling health, gender and equity challenges in breast cancer Prue Francis \| AUS
10.00am – 10.15am	Discussion
10.15am – 10.45am	Morning tea
10.45am – 12.40pm	Is it less or is it more? Questions in detecting and treating Early Breast Cancer Chair: Monica Saini
10.45am – 11.10am	Evolving algorithms for breast screening Debra Ikeda \| USA
11.10am – 11.30pm	Adjuvant CDK4/6 inhibition – a step closer to standard of care? Nick McAndrew \| USA
11.30am – 11.50am	What to do in the axilla after NACT? Cliona Kirwan \| UK
11.50am – 12.10pm	Treating small triple negative breast cancers Lauren Brown \| NZ & AUS
12.10am – 12.40pm	Debate: It’s time for more proactive imaging surveillance in early breast cancer follow-up Proposing speaker: Belinda Yeo \| AUS Opposing speaker: Richard Isaacs \| NZ
12.40pm – 1.40pm	Lunch

1.40pm – 3.15pm	Parallel stream A: Challenges in advanced breast cancer Chair: Sarah Barton	Parallel stream B: Considerations in breast conservation Chair: Peter Chin
1.40pm – 2.05pm	After CDK4/6i – new agents, new ideas Aditya Bardia \| USA (online)	Considerations in breast conservation panel Christobel Saunders \| AUS, Alex Brown \| NZ, Jayaram Mohanamurali \| NZ, Christine Mouat \| NZ, Cliona Kirwan \| UK
2.05pm – 2.25pm	Treating HER2+ brain metastases Nick McAndrew \| USA	RT and Oncoplastic surgery: Perspective of a Radiation Oncologist Jayaram Mohanamurali \| NZ
2.25pm – 2.45pm	Optimal use of systemic therapy options in metastatic TNBC Sara Hurvitz, USA (online)	Multifocality: Choosing BCS vs Mastectomy – TBC Christine Mouat \| NZ
2.45pm – 2.55pm	Discussion	Low risk Ipsilateral Recurrence: Is BCS now standard of care? Alex Brown \| NZ
2.55pm – 3.15pm	Oligometastases and oligoprogression – Global thinking, local trials Steven David \| Australia	Vacuum-excision of low-risk cancers – should we go there? Cliona Kirwan \| UK
3.15pm – 3.45pm	Afternoon tea
3.45pm – 5.15pm	Breast SIG meeting (Open to SIG members, NZ SMOs and NZ nurses) Chair: Marion Kuper \| NZ
3.55pm – 4.00pm	Update on Breast SIG Online Joanna Jones
4.00pm – 4.10pm	Discussion: Key 2024 updates to ABC-NZ guidelines Marion Kuper \| NZ
4.10pm – 4.30pm	CDK 4/6 inhibitor update and NZ perspective Sarah Barton \| NZ
4.30pm – 4.45pm	Update on surgical localisation data collection Paul Samson
4.45pm – 5.05pm	Medsafe and Pharmac updates / BSIG submissions BCAC / Joanna Jones
5.05pm – 5.15pm	Clinical trial updates Trial PIs
5.15pm – 5.30pm	SIG meeting close
5.30pm - 7.30pm	Welcome Reception HeyDay craft brewery and gin joint \| 264 Cuba Street, Te Aro

8.00am – 8.30am	Registration open with coffee & breakfast
8.00am – 9.30 am	Breakfast Symposium: Look who’s talking – comms & PROMs Chair: Joanna Jones
8.30am – 8.50 am	What the patient needs to hear – and what she actually hears Andi Shirtcliffe \| NZ Breast cancer survivor
8.50am – 9.10 am	Shared Decision-Making Lesley Fallowfield \| UK (online)
9.10am – 9.30am	Deal or No Deal: Can you prevent or reverse a patient’s “No” to recommended treatment (and should you?) Fran Boyle \| AUS
9.30am – 10.00am	The patient speaks: PROMs in clinical practice – learnings, early results and patient feedback on ABC pro Fran Boyle \| AUS & Marion Kuper \| NZ
10.00am – 10.05am	Q+A discussion
10.05am – 10.30am	Morning tea
10.30am – 11.15am	PET Projects Chairs: Debra Ikeda \| USA and David Porter
10.35am – 10.55am	FDG-PET in staging and diagnosis of Stage IIb-IV breast cancer – a preview of the new EANM/SMMNI guideline Sofia Vaz \| Portugal (online)
10.55am – 11.15am	New PET opportunities in NZ Remy Lim \| NZ
11.15am – 12.30pm	Controversies in Early Breast Cancer Chairs: David Porter and Dan Cocker
11.15am – 11.45am	Debate: It’s time to mainstream the omission of radiation therapy in low-risk hormone receptor positive EBC Proposing: Alex Brown \| NZ Opposing: Steven David \| AUS
11.45am – 12.05pm	The poor cousin: challenges in diagnosing, staging and treating lobular breast cancer Belinda Yeo \| AUS
12.05pm – 12.25pm	Time for a Kinsensus? Should Ki67 become routine practice for breast cancer staging in NZ (and how?) Nirmala Pathmanathan \| AUS (online), Reuben Broom \| NZ
12.25pm – 12.30pm	Q+A discussion
12.30pm – 1.00pm	NURSES ONLY: LUNCHTIME SESSION: Endocrine Therapy Update
12.30pm – 1.30pm	Lunch
1.30pm – 3.05pm	New order Chair: Shahistha Naidoo
1.35pm – 1.55pm	AI gets real in radiology Debra Ikeda \| USA
1.55pm – 2.15pm	Pre-operative Radiation – Who, where, why? Farshad Foroudi \| AU (online)
2.15pm – 2.35pm	The role of neoadjuvant immunotherapy in ER+/HER2- breast cancer Lauren Brown \| NZ + AUS
2.35pm – 2.50pm	Hypercoagulability – a risk, a biomarker and a treatment target Cliona Kirwan \| UK
2.50pm – 3.05pm	Discussion
3.05pm – 3.25pm	Afternoon tea
3.25pm – 5.00pm	Getting better – doing the mahi for improved outcomes Chair: Edmond Ang
3.30pm – 3.50pm	What role can primary care play in helping to lock in – and extend – the gains made for Māori and Pacific women with breast cancer? Mihi Blair \| NZ
3.50pm – 4.20pm	Breast Cancer QPIs – Te Aho o Te Kahu and the Clinical Working Group report on selected QPIs Sarah Barton \| NZ , Te Aho o Te Kahu – Gabrielle Nicholson & Kayla Cook \| NZ
4.20pm – 5.00pm	How 2023’s meetings changed my practice – a multidisciplinary round-up from our guest speakers Chair: Reuben Broom \| NZ ; Panelists: Cliona Kirwan \| UK, Nick McAndrew \| USA, Belinda Yeo \| AUS
From 5.00pm	Friday session ends
7.00pm – 10.30pm	Gala dinner The Grand Hall, Parliament \| Molesworth Street

8.00am – 8.30am	Light breakfast
8.30am – 12.00pm	Saturday Session: Younger women and breast cancer
	Treating younger women with breast cancer – an interactive session of presentations, discussions and polls. Chairs: Eletha Taylor, Reuben Broom \| NZ
	Variation in care – how does treatment of women <40 vs >40 differ in NZ? Data from Te Rēhita Mate Ūtaetae - Breast Cancer Foundation National Register
8.45am - 9.10am	An evidence-based vision for treating young women with breast cancer Anna Weiss \| US (online)
9.10am - 9.25am	Earlier detection for young women: Further analysis and UK experience of a screening blood test for breast cancer Cliona Kirwan \| UK
9.25am - 9.40am	Surgical choices – evidence and practice. It’s complicated! Christobel Saunders \| AUS
9.40am - 9.55am	Access to reconstructive surgery today Marcus Bisson \| NZ
9.55am - 10.10am	Discussion
10.00am – 10.40am	Morning tea
	Saturday Session: Younger women and breast cancer cont.
10.45am – 11:05am	Younger women - when to add chemotherapy to endocrine therapy; genomic assays. Prue Francis \| AUS
11.05am - 11.25am	Preventing and managing long term toxicity in younger women Belinda Yeo \| AUS
11.25am - 11.50am	Case discussion – Considerations for de-escalation
11.50am-12.00pm	Conference close